Woman and Man
- | Country :
- Austria
- | organs : -
- | Specialty : -
Extract
This study evaluated the efficacy and safety of Avastin (bevacizumab, 5 mg/kg intravenously every 2 weeks) in patients with multiple myeloma, relapsed/refractory after at least 2 lines of prior therapy.
Inclusion criteria
- Multiple myeloma